Debates on tobacco and nicotine policy within the European Union have often been characterised by strong views and high levels of engagement. This reflects the importance of the issue. Tobacco use remains a leading cause of preventable disease, and decisions taken by policymakers have long-term implications for public health across Member States.
However, the intensity of these discussions can sometimes make it more difficult to focus on a central objective: identifying regulatory approaches that produce measurable improvements in health outcomes. As the European Union continues to review frameworks such as the Tobacco Products Directive (TPD) and the Tobacco Excise Directive (TED), the quality of policy discussion may be as important as the substance of the policies themselves.
The Nature of Policy Debate
Public health policymaking involves balancing scientific evidence, ethical considerations, and societal priorities. In the context of tobacco control, this often includes discussions around risk, prevention, harm reduction, and the role of emerging product categories.
Given the complexity of these issues, it is not surprising that debates can become polarised. Different stakeholders may emphasise different aspects of the evidence or prioritise different policy outcomes. While this diversity of perspectives can be valuable, it can also lead to situations where discussions focus more on positions than on outcomes.
Johan Nissinen, former Member of the European Parliament and now working with the Global Institute for Novel Nicotine (GINN), has observed this dynamic firsthand during his time in EU policymaking.
“Some of the most intense discussions I witnessed in Parliament were on tobacco policy,” Nissinen noted in conversations with GINN. “People cared deeply about the issue, which is important. But the most productive conversations were often the ones where the volume came down and the focus shifted to the evidence.”
This perspective highlights the importance of maintaining a structured and evidence-based approach to policymaking, particularly in areas with significant public health implications.
Evidence as a Common Ground
Scientific evidence provides a foundation for evaluating policy options and their likely impact. In tobacco control, this includes research on disease burden, behavioural patterns, product characteristics, and the effectiveness of different regulatory measures.
While interpretations of evidence may vary, a shared commitment to evidence-based analysis can help create a common ground for discussion. This is particularly relevant in the context of evolving nicotine product markets, where new data continues to emerge and regulatory frameworks must adapt accordingly.
An evidence-based approach does not eliminate disagreement, but it can help ensure that policy debates remain focused on measurable outcomes rather than on assumptions or perceptions alone.
From Theory to Practice
Public health policies are often designed with clear theoretical objectives. However, the effectiveness of these policies depends on how they function in real-world conditions.
In tobacco control, this includes understanding how individuals respond to regulatory measures such as product restrictions, pricing policies, and information campaigns. Behavioural responses are influenced by a range of factors, including accessibility, perceived risk, social context, and personal motivation.
Nissinen has emphasised the importance of grounding policy discussions in practical outcomes.
“The point that GINN continues to make is not radical,” he explained. “It is about designing rules that reduce harm in practice, not just in theory.”
This observation reflects a broader principle in public health governance: policies should be evaluated based on their ability to achieve intended outcomes, particularly in reducing disease and improving population health.
Maintaining High Standards
An evidence-based approach to policymaking does not imply lowering regulatory standards. On the contrary, it requires careful consideration of how different measures contribute to public health objectives.
Strong protections for young people, clear product standards, and effective enforcement mechanisms remain essential components of tobacco control policy. At the same time, regulatory frameworks must also account for the realities of existing behaviour, particularly among individuals who continue to smoke.
Nissinen addressed this balance directly:
“This is not about lowering standards,” he noted. “It is about being honest about what actually helps people move away from cigarettes.”
This perspective underscores the importance of aligning policy design with both scientific evidence and behavioural insights, while maintaining a high level of public health protection.
The Role of Constructive Dialogue
As the European Union reviews the TPD and TED, policymakers, researchers, and stakeholders will continue to engage in discussions about the future of tobacco and nicotine regulation.
Constructive dialogue plays a critical role in this process. When discussions are grounded in evidence and focused on outcomes, they are more likely to produce policies that are both effective and proportionate.
Reducing the intensity of debate does not diminish its importance. Rather, it can create space for more nuanced analysis and more effective decision-making.
Looking Ahead
The revision of key EU tobacco policy frameworks presents an opportunity to reassess both the content of regulation and the way in which policy discussions are conducted.
Ensuring that debates remain focused on evidence and real-world outcomes may help support the development of regulatory frameworks that are both robust and adaptable. This, in turn, may contribute to more effective strategies for reducing smoking-related harm across Europe.
In complex policy areas, strong opinions are inevitable. However, as experience has shown, progress is often achieved not through louder arguments, but through clearer evidence and more focused discussion.
In this context, maintaining an evidence-based approach may be one of the most important tools available to policymakers seeking to improve public health outcomes.
